Emcure Pharmaceuticals intimates schedule for participation in multiple analyst and investor conferences from May to June 2026.
Meetings include group and one-on-one sessions at events hosted by Ambit Capital, 360 ONE Capital, Axis Capital, and ICICI Securities.
The company confirms no unpublished price sensitive information will be shared during these tentative meetings.
Disclosure is made pursuant to SEBI LODR Regulations, 2015 as a regulatory compliance requirement.